Comparison of the dynamics and correlates of transmission of Herpes Simplex Virus-1 (HSV-1) and Varicella-Zoster Virus (VZV) in a sample of the Israeli population
- PMID: 17668279
- DOI: 10.1007/s10654-007-9169-3
Comparison of the dynamics and correlates of transmission of Herpes Simplex Virus-1 (HSV-1) and Varicella-Zoster Virus (VZV) in a sample of the Israeli population
Abstract
Herpes simplex virus types-1 (HSV-1) and Varicella-zoster virus (VZV) are herpes viruses that share many characteristics. However, HSV-1 spreads by close contact while VZV spreads mainly by the airborne route. In this study we compared the dynamics and correlates of transmission of these viruses in the same population. In 2000-2001, 1555 sera from an age-stratified general population sample were tested using commercial ELISA kits to measure type-specific HSV-1 and varicella IgG antibodies. The VZV seroprevalence increased rapidly with age reaching 50% seropositivity by the age of 3 years, while HSV-1 reached 50% seropositivity at the age of 14 years. The highest VZV force of infection was in the 3.5-5.5-year age group followed by the 5.5-10.5 years age group, while for HSV-1 the age specific force of infection was substantially lower and stable over the various age groups. Multivariate analysis revealed that HSV-1 seroprevalence was significantly, independently associated with age, country of birth, country of origin, ethnicity, socio-economic status and VZV sero-status. Only age, country of origin and HSV-1 sero-status were found to be associated with VZV seropositivity. In developed countries such as Israel the transmission of VZV is much quicker and less dependent on socioeconomic status as compared with HSV-1.
Similar articles
-
Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.Vaccine. 2013 Oct 17;31(44):5067-74. doi: 10.1016/j.vaccine.2013.08.077. Epub 2013 Sep 7. Vaccine. 2013. PMID: 24021305
-
Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines.Infection. 2006 Aug;34(4):208-13. doi: 10.1007/s15010-006-6604-4. Infection. 2006. PMID: 16896579
-
Seroprevalence of herpes simplex virus 1 and 2 and correlates of infection in Israel.J Infect. 2006 May;52(5):367-73. doi: 10.1016/j.jinf.2005.08.005. Epub 2005 Oct 6. J Infect. 2006. PMID: 16213591
-
[Vertical transmission of alpha herpes virus].Nihon Rinsho. 2000 Apr;58(4):871-6. Nihon Rinsho. 2000. PMID: 10774208 Review. Japanese.
-
A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation.J Gen Virol. 2015 Jul;96(Pt 7):1581-602. doi: 10.1099/vir.0.000128. Epub 2015 Mar 20. J Gen Virol. 2015. PMID: 25794504 Free PMC article. Review.
Cited by
-
Coronavirus (SARS-CoV-2) Pandemic: Future Challenges for Dental Practitioners.Microorganisms. 2020 Oct 31;8(11):1704. doi: 10.3390/microorganisms8111704. Microorganisms. 2020. PMID: 33142764 Free PMC article. Review.
-
Recent trends in publications in the European Journal of Epidemiology.Eur J Epidemiol. 2008;23(12):757-60. doi: 10.1007/s10654-008-9305-8. Eur J Epidemiol. 2008. PMID: 19039670 No abstract available.
-
Covid-19 Pandemic: What Changes for Dentists and Oral Medicine Experts? A Narrative Review and Novel Approaches to Infection Containment.Int J Environ Res Public Health. 2020 May 27;17(11):3793. doi: 10.3390/ijerph17113793. Int J Environ Res Public Health. 2020. PMID: 32471083 Free PMC article.
-
Toxoplasma gondii seropositivity and co-infection with TORCH pathogens in high-risk patients from Qatar.Am J Trop Med Hyg. 2010 Apr;82(4):626-33. doi: 10.4269/ajtmh.2010.09-0530. Am J Trop Med Hyg. 2010. PMID: 20348511 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical